417 related articles for article (PubMed ID: 36277335)
1. Light-activated nanomaterials for tumor immunotherapy.
Wang F; Duan H; Xu W; Sheng G; Sun Z; Chu H
Front Chem; 2022; 10():1031811. PubMed ID: 36277335
[TBL] [Abstract][Full Text] [Related]
2. Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy.
Sui X; Jin T; Liu T; Wu S; Wu Y; Tang Z; Ren Y; Ni D; Yao Z; Zhang H
Front Chem; 2020; 8():804. PubMed ID: 33094098
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterials: small particles show huge possibilities for cancer immunotherapy.
Chen Z; Yue Z; Yang K; Li S
J Nanobiotechnology; 2022 Nov; 20(1):484. PubMed ID: 36384524
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
Yuan C; Liu Y; Wang T; Sun M; Chen X
ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterials in tumor immunotherapy: new strategies and challenges.
Zhu X; Li S
Mol Cancer; 2023 Jun; 22(1):94. PubMed ID: 37312116
[TBL] [Abstract][Full Text] [Related]
8. Carbon Nanomaterials: Emerging Roles in Immuno-Oncology.
Patrick B; Akhtar T; Kousar R; Huang CC; Li XG
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047572
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharide-based nanomedicines for cancer immunotherapy: A review.
Zeng Y; Xiang Y; Sheng R; Tomás H; Rodrigues J; Gu Z; Zhang H; Gong Q; Luo K
Bioact Mater; 2021 Oct; 6(10):3358-3382. PubMed ID: 33817416
[TBL] [Abstract][Full Text] [Related]
10. Recent strategies for evoking immunogenic Pyroptosis in antitumor immunotherapy.
He Z; Feng D; Zhang C; Chen Z; Wang H; Hou J; Li S; Wei X
J Control Release; 2024 Feb; 366():375-394. PubMed ID: 38142962
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.
Li SR; Huo FY; Wang HQ; Wang J; Xu C; Liu B; Bu LL
J Nanobiotechnology; 2022 Jun; 20(1):277. PubMed ID: 35701847
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials: A powerful tool for tumor immunotherapy.
Chen Z; Yue Z; Wang R; Yang K; Li S
Front Immunol; 2022; 13():979469. PubMed ID: 36072591
[TBL] [Abstract][Full Text] [Related]
13. Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.
Yu S; Wang Y; He P; Shao B; Liu F; Xiang Z; Yang T; Zeng Y; He T; Ma J; Wang X; Liu L
Front Oncol; 2022; 12():809304. PubMed ID: 35198442
[TBL] [Abstract][Full Text] [Related]
14. Nanomaterials for cancer immunotherapy.
Song W; Musetti SN; Huang L
Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy.
Zhao B; Li X; Kong Y; Wang W; Wen T; Zhang Y; Deng Z; Chen Y; Zheng X
Front Bioeng Biotechnol; 2022; 10():1010724. PubMed ID: 36159668
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy.
Chang M; Hou Z; Wang M; Li C; Lin J
Adv Mater; 2021 Jan; 33(4):e2004788. PubMed ID: 33289219
[TBL] [Abstract][Full Text] [Related]
18. Near-Infrared Photoactivatable Immunomodulatory Nanoparticles for Combinational Immunotherapy of Cancer.
Yu N; Ding M; Li J
Front Chem; 2021; 9():701427. PubMed ID: 34109160
[TBL] [Abstract][Full Text] [Related]
19. Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle.
Li Q; Shi Z; Zhang F; Zeng W; Zhu D; Mei L
Acta Pharm Sin B; 2022 Jan; 12(1):107-134. PubMed ID: 35127375
[TBL] [Abstract][Full Text] [Related]
20. Biogenic nanoparticles as immunomodulator for tumor treatment.
Cheng K; Kang Q; Zhao X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1646. PubMed ID: 32464709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
